Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARK MATTHEWS

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1245348390
CMS profile
10629
Location
MYRTLE BEACH, SC

General Payments · PY2018–2024

$3,362.02

  • Reported across 169 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$830.65

38 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $830.65 38

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $306.46 19
PY2019 $496.92 24
PY2020 $510.71 23
PY2021 $728.21 39
PY2022 $304.17 16
PY2023 $184.90 10
PY2024 $830.65 38

Payment records · PY2024 (38)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $14.44 02/07/2024 Food and Beverage Undisputed 01/23/2026 1093886332 CMS
Alexion Pharmaceuticals, Inc. $17.59 03/20/2024 Food and Beverage Undisputed 01/23/2026 1093933151 CMS
Alexion Pharmaceuticals, Inc. $17.66 10/08/2024 Food and Beverage Undisputed 01/23/2026 1094008306 CMS
Amgen Inc. $13.44 03/28/2024 Food and Beverage Undisputed 01/23/2026 1111646324 CMS
Amgen Inc. $19.49 05/01/2024 Food and Beverage Undisputed 01/23/2026 1111646326 CMS
Amgen Inc. $20.93 08/20/2024 Food and Beverage Undisputed 01/23/2026 1111646328 CMS
Amgen Inc. $14.83 11/20/2024 Food and Beverage Undisputed 01/23/2026 1111646322 CMS
Aurinia Pharma U.S., Inc. $21.57 04/29/2024 Food and Beverage Undisputed 01/23/2026 1150687129 CMS
Aurinia Pharma U.S., Inc. $13.29 10/03/2024 Food and Beverage Undisputed 01/23/2026 1150687131 CMS
Averitas Pharma Inc. $33.70 03/02/2024 Food and Beverage Undisputed 01/23/2026 1133436024 CMS
Averitas Pharma Inc. $28.54 10/17/2024 Food and Beverage Undisputed 01/23/2026 1133436028 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.55 02/02/2024 Food and Beverage Undisputed 01/23/2026 1117931199 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.79 05/14/2024 Food and Beverage Undisputed 01/23/2026 1117931201 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.48 09/18/2024 Food and Beverage Undisputed 01/23/2026 1117931197 CMS
Corcept Therapeutics $23.23 09/27/2024 Food and Beverage Undisputed 01/23/2026 1117761641 CMS
Corcept Therapeutics $16.29 10/10/2024 Food and Beverage Undisputed 01/23/2026 1117761671 CMS
Daiichi Sankyo Inc. $17.71 01/22/2024 Food and Beverage Undisputed 01/23/2026 1089453662 CMS
GlaxoSmithKline, LLC. $13.37 01/31/2024 Food and Beverage Undisputed 01/23/2026 1116185847 CMS
Kiniksa Pharmaceuticals International, plc $14.02 06/04/2024 Food and Beverage Undisputed 01/23/2026 1154878902 CMS
Kyowa Kirin, Inc. $26.04 12/11/2024 Food and Beverage Undisputed 01/23/2026 1127036860 CMS
Lilly USA, LLC $13.95 01/17/2024 Food and Beverage Undisputed 01/23/2026 1135156911 CMS
Lilly USA, LLC $14.18 06/06/2024 Food and Beverage Undisputed 01/23/2026 1135167708 CMS
Medtronic, Inc. $108.60 04/10/2024 Food and Beverage Undisputed 01/23/2026 1117126275 CMS
Novartis Pharmaceuticals Corporation $13.25 12/02/2024 Food and Beverage Undisputed 01/23/2026 1087112826 CMS
Novo Nordisk Inc $24.46 04/24/2024 Food and Beverage Undisputed 01/23/2026 1097192909 CMS
Novo Nordisk Inc $30.04 10/16/2024 Food and Beverage Undisputed 01/23/2026 1097520927 CMS
Otsuka America Pharmaceutical, Inc. $23.28 02/09/2024 Food and Beverage Undisputed 01/23/2026 1118937878 CMS
Otsuka America Pharmaceutical, Inc. $22.39 05/15/2024 Food and Beverage Undisputed 01/23/2026 1118937880 CMS
Radius Health, Inc. $24.48 10/07/2024 Food and Beverage Undisputed 01/23/2026 1089973157 CMS
Radius Health, Inc. $17.56 12/09/2024 Food and Beverage Undisputed 01/23/2026 1089973161 CMS
SANOFI-AVENTIS U.S. LLC $13.11 08/15/2024 Food and Beverage Undisputed 01/23/2026 1139700809 CMS
SANOFI-AVENTIS U.S. LLC $14.47 09/26/2024 Food and Beverage Undisputed 01/23/2026 1139700843 CMS
UCB, Inc. $18.21 01/25/2024 Food and Beverage Undisputed 01/23/2026 1143177483 CMS
UCB, Inc. $16.32 03/21/2024 Food and Beverage Undisputed 01/23/2026 1143177485 CMS
UCB, Inc. $21.34 07/02/2024 Food and Beverage Undisputed 01/23/2026 1143177487 CMS
UCB, Inc. $19.42 10/21/2024 Food and Beverage Undisputed 01/23/2026 1143177489 CMS
UCB, Inc. $20.26 11/21/2024 Food and Beverage Undisputed 01/23/2026 1143177491 CMS
Vital Connect, Inc $23.37 09/03/2024 Food and Beverage Undisputed 01/23/2026 1120138123 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.